Contribution: Industrial Research Assistance Program – Contributions to Firms
Alpha-9 Theranostics Inc.
$344,000.00
Development of novel radiopharmaceuticals for the treatment of prostate cancer
EF 2021-22 · 2021-07-01
Résumé
This project will support the pre-clinical development of novel therapeutic radiopharmaceuticals that selectively bind to prostate-specific membrane antigen (PSMA), as potential treatments for prostate cancer.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver|Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
776454530
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 1 | 2021-07-01 | 2021-22 | $300,000.00 |
| 2 | 2021-07-01 | 2021-22 | $344,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The total amended value is 44,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 44 000 dollars.
Agreement End Date
2023-03-31
Agreement Number
982291
Agreement Start Date
2021-07-01
Agreement Title
Development of novel radiopharmaceuticals for the treatment of prostate cancer
Agreement Title (French)
Développement de nouveaux produits radiopharmaceutiques pour le traitement du cancer de la prostate
Agreement Type
Contribution
Agreement Value
$344,000.00
Amendment Date
2023-01-24
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will support the pre-clinical development of novel therapeutic radiopharmaceuticals that selectively bind to prostate-specific membrane antigen (PSMA), as potential treatments for prostate cancer.
Description (French)
Ce projet soutiendra le développement préclinique de nouveaux produits radiopharmaceutiques thérapeutiques qui se lient sélectivement à l'antigène membranaire propre à la prostate, comme traitements potentiels du cancer de la prostate.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver East
Federal Riding (French)
Vancouver-Est
Federal Riding Number
59035
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
776454530
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Alpha-9 Theranostics Inc.
Recipient Postal Code
V5T 1M4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q4-982291
